Łukasz Sznajder is an expert in molecular genetics, with particular interest in human hereditary neuropsychiatric and neuromuscular disorders.
Sznajder is an assistant professor of chemistry and biochemistry within UNLV’s College of Sciences. His long-term goal is to strengthen our understanding of the molecular mechanisms behind neurogenetic disorders caused by repetitive DNA sequences and RNA mis-processing, such as myotonic dystrophy, amyotrophic lateral sclerosis (ALS), and ASD.
For nearly two decades, both in the United States and Poland, he has conducted numerous studies about deciphering disease mechanisms, characterizing mouse models, identifying blood biomarkers, and developing therapeutic approaches for life-threatening human diseases.
Sznajder has 19 peer-reviewed articles in journals such as Nature Neuroscience, Nature Communications, Nature Biomedical Engineering, and PNAS. He's been consistently funded by both federal agencies and non-profit organizations, including the National Institute of General Medical Sciences, Myotonic Dystrophy Foundation, and Muscular Dystrophy Association.
As diagnoses of autism spectrum disorder rise, a UNLV researcher's breakthrough could lead to new forms of treatment
The UNLV researchers uncovered a connection to a type of neuromuscular disease called myotonic dystrophy. “This research is providing an important piece of information,” Łukasz Sznajder, geneticist and professor at UNLV, said. “It’s showing a pathway from the mutation in the gene to the outcome, which is the development of autism.”
People with a little-known genetic muscle condition may be 14 times more likely to develop autism, a study published this week from the University of Nevada Las Vegas (UNLV) suggests.